Brain Cancer
German Children's Cancer Center Aims to Expand Global Access to Methylation-Based Tumor Classifier
Premium
The program will provide funding and expertise to clinics in low-income countries to run methylation array-based assays to classify central nervous system tumors in children.
Biocept Prices $5M Public Offering
The San Diego-based company plans to use the proceeds to advance its cerebral spinal fluid liquid biopsy assay, as well as to boost its working capital.
Dxcover Raises $11.9M to Bring Infrared Spectroscopy Cancer Detection Assay to Market
The firm is advancing what it describes as an infrared spectroscopy-based platform for early cancer detection, with initial data in brain tumors.
The company recently presented data on the use of its spectroscopic liquid biopsy test for the early-stage detection of multiple cancers at ASCO.
Brain Cancer Canada Funds Development of New Dx Sequencing Assay at St. Michael's Hospital
The group plans to develop and implement a custom gene sequencing assay intended to help rapidly diagnose brain cancers and inform molecularly targeted treatment.